PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION

Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients

2021-02-26
(Press-News.org) Treating critically ill COVID-19 patients with drugs typically used for rheumatoid arthritis may significantly improve survival, a landmark study has found.

The findings, which were announced in January and have now been peer-reviewed and published in the New England Journal of Medicine, come from the REMAP-CAP trial, which evaluates the effect of treatments on a combination of survival and length of time patients need support in an intensive care unit (ICU).

Initial findings reported in November showed that tocilizumab, a drug used to treat arthritis, was likely to improve outcomes among critically ill COVID-19 patients. But the impact on patient survival and length of time on organ support in ICU was not clear at that time.

The full, peer-reviewed analysis shows that tocilizumab and a second drug called sarilumab - both types of immune modulators called IL-6 receptor antagonists - have a significant impact on patient survival, reducing mortality by 8.5%.

Furthermore, the treatment also improved recovery so that on average patients were able to be discharged from the intensive care unit (ICU) about a week earlier.

"We are delighted that our full results are now published after peer review. This confirms the robustness of our findings, that tocilizumab and sarilumab can reduce deaths by nearly a quarter, in the sickest patients with COVID," said Professor Anthony Gordon, Chair in Anaesthesia and Critical Care at Imperial College London and a Consultant in Intensive Care Medicine at Imperial College Healthcare NHS Trust.

"We also saw that it helped speed up recovery, so that on average patients were discharged from ICU a week earlier and leave hospital two weeks earlier. It is great news to know that several thousand patients have already benefited from these drugs being used within the NHS. Other studies have now confirmed our results and so even more patients will continue to benefit.

"We are hugely grateful to all the NHS staff who helped make the trial happen and to all patients and their families who agreed to take part in this trial. Together we are all helping to tackle this dreadful disease."

Tocilizumab and sarilumab are immunosuppressive drugs used to treat rheumatoid arthritis. They were two of several immune modulation treatments included in the REMAP-CAP trial. At the end of last year, positive early findings on tocilizumab were released before the full data had been collected. With the full analysis now available, researchers are confident the findings will continue to bring clinical benefit for the sickest patients with COVID-19.

Full findings

At the time of full analysis 353 patients had been assigned to tocilizumab, 48 to sarilumab and 402 to control. The majority of patients were also treated with corticosteroids and were receiving respiratory support.

The trial data yielded an odds ratio of 1.64 for a better outcome with tocilizumab, and 1.76 for sarilumab, compared to no immune modulation, with a high degree of statistical certainty (>99.5% probability that both treatments are superior to no immune modulation).

Hospital mortality was 27.3% among patients receiving IL-6 receptor agonists (28.0% for tocilizumab, 22.2% for sarilumab) compared with 35.8% for control group. This means for every 12 patients treated, one life would be saved.

Professor Gordon added: "Previous trials using IL-6 receptor agonists have showed no clear benefit on either disease progression or survival in COVID-19 patients, but those studies included less severely ill patients and started treatment at different stages in the disease course.

"A crucial difference may be that in our study, critically ill patients were enrolled within 24 hours of starting organ support. This highlights a potential early window for treatment where the sickest patients may gain the most benefit from immune modulation treatment."

Study co-author Christopher Seymour, M.D., associate professor of critical care medicine and emergency medicine at the University of Pittsburgh School of Medicine (UPMC), said: "As soon as the immune modulator results hit our statistical trigger, these drugs were immediately incorporated at UPMC and other North American REMAP-CAP partners as our standard treatment for patients critically ill with COVID-19.

"In addition, the overall design of REMAP-CAP allows us to test multiple interventions concurrently and over time. So, while we implement new evidence-based care practices, we continue to test other promising therapies in patients with both moderate and severe COVID-19."

REMAP-CAP study is led by Imperial College London and the Intensive Care National Audit & Research Centre (ICNARC) in the UK and University Medical Center Utrecht in Europe. It began investigating treatments for COVID-19 in March 2020, enrolling hospitalised patients with either moderate or severe (requiring ICU care) COVID-19 disease.

The study design randomises patients to multiple combinations of treatments, enabling researchers to evaluate different treatments for COVID-19, including antivirals, drugs which modulate the immune response, and therapies that modulate or support other vital aspects of the body's response to the virus.

To date, over 5,500 patients in 15 countries have been enrolled at more than 290 hospitals worldwide and randomised to multiple treatment combinations. The effects of interventions are assessed separately for moderate and severely ill patients.

The latest findings on tocilizumab and sarilumab add to REMAP-CAP findings from earlier this year, which found that hydrocortisone steroid treatment improved recovery among critically ill COVID-19 patients.

This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Department of Health and Social Care. As of February 2021 75% of all study participants had been recruited in the UK through the NIHR's Clinical Research Network (CRN).

The study is supported in the UK by the National Institute for Health Research (NIHR) and Imperial College London & ICNARC are partners in the EU funded PREPARE consortium.

*This is an updated press release, based on findings from January 2021* https://www.imperial.ac.uk/news/211514/arthritis-drugs-reduce-mortality-time-icu/

INFORMATION:

NOTES TO EDITORS

'Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19' by The REMAP-CAP Investigators is published in the New England Journal of Medicine.

* Reduction in mortality measured using pooled hospital mortality for both IL-6 receptor antagonist (27.3% (108/395) versus control (35.8% (142/397)). Hospital mortality was 28.0% (98/350) for tocilizumab, 22.2% (10/45) for sarilumab. Eleven patients are still to be followed up.

** Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19, JAMA, 2020 - https://jamanetwork.com/journals/jama/fullarticle/2770278

About REMAP-CAP REMAP-CAP (The Randomized Embedded Multifactorial Adaptive Platform for Community Acquired Pneumonia) is an ongoing adaptive clinical trial involving more than 3000 COVID-19 patients at more than 290 clinical sites around the world.

REMAP-CAP continues to evaluate multiple other study questions, including therapeutic anticoagulation, antiplatelet drugs, apremilast, eritoran, anakinra, vitamin C, simvastatin, convalescent plasma, macrolides, and antibiotics.

For more information, see the ICNARC REMAP-CAP website https://www.icnarc.org/Our-Research/Studies/Remap-Cap/About

About Imperial College London Imperial College London is one of the world's leading universities. The College's 20,000 students and 8,000 staff are working to solve to the biggest challenges in science, medicine, engineering and business.

Imperial is the world's fifth most international university, according to Times Higher Education, with academic ties to more than 150 countries. Reuters named the College as the UK's most innovative university because of its exceptional entrepreneurial culture and ties to industry.

Imperial staff, students and alumni are working round-the-clock to combat COVID-19. Imperial has nearly two thousand key workers, and is at the forefront of coronavirus epidemiology, virology, vaccine development and diagnostics. More than one thousand Imperial staff and students are volunteering to support the NHS. http://www.imperial.ac.uk/

About NIHR The National Institute for Health Research (NIHR) is the nation's largest funder of health and care research. The NIHR:

Funds, supports and delivers high quality research that benefits the NHS, public health and social care

Engages and involves patients, carers and the public in order to improve the reach, quality and impact of research

Attracts, trains and supports the best researchers to tackle the complex health and care challenges of the future

Invests in world-class infrastructure and a skilled delivery workforce to translate discoveries into improved treatments and services

Partners with other public funders, charities and industry to maximise the value of research to patients and the economy

The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR supports applied health research for the direct and primary benefit of people in low- and middle-income countries, using UK aid from the UK government.



ELSE PRESS RELEASES FROM THIS DATE:

New machine learning tool facilitates analysis of health information, clinical forecasting

2021-02-25
Clinical research requires that data be mined for insights. Machine learning, which develops algorithms to find patterns, has difficulty doing this with data related to health records because this type of information is neither static nor regularly collected. A new study developed a transparent and reproducible machine learning tool to facilitate analysis of health information. The tool can be used in clinical forecasting, which can predict trends as well as outcomes in individual patients. The study, by a researcher at Carnegie Mellon University (CMU), appears in Proceedings of Machine Learning Research. "Temporal Learning Lite, or TL-Lite, is a visualization and forecasting tool to ...

Scientists investigated more thoroughly Walker breakdown in 3D magnetic nanowires

Scientists investigated more thoroughly Walker breakdown in 3D magnetic nanowires
2021-02-25
Physicists from Russia, Chile, Brazil, Spain, and the UK, have studied how the magnetic properties change in 3D nanowires, promising materials for various magnetic applications, depending on the shape of their cross-section. Particularly, they more deeply probed into the Walker breakdown phenomenon, on the understanding of which the success of the implementation of the future electronics devices depends. The research outcome appears in Scientific Reports. The cross-sectional geometry of a three-dimensional nanowire affects the domain wall dynamics and therefore is crucial for their control. In turn, managing the DW dynamics under various external conditions is necessary in order to realize the future electronics and computing devices, operating on new physical principles. ...

A tangled food web

2021-02-25
Born in food web ecology, the concept of trophic levels -- the hierarchy of who eats who in the natural world -- is an elegant way to understand how biomass and energy move through a natural system. It's only natural that the idea found its way into the realm of aquaculture, where marine and freshwater farmers try to maximize their product with efficient inputs. "It's often used as a measure of how sustainable it is to harvest or consume that species," said Rich Cottrell(link is external), a postdoctoral researcher at UC Santa Barbara's National Center for Ecological Analysis & Synthesis (NCEAS). As plants (level 1) become food to plant eaters (level 2), who in turn are consumed by carnivores (level 3) and so on, the amount of energy ...

Identifying patient-specific differences to treat HCM with precision medicine

2021-02-25
Hypertrophic cardiomyopathy (HCM) is a cardiovascular disease characterized by thickening of the left ventricle, otherwise known as the main squeezing chamber of the heart. HCM is best known for causing sudden death in athletes but can occur in persons of any age, often without symptoms. While frequently discussed in the context of genetics, most patients with HCM do not have a known genetic variant. Investigators from Brigham and Women's Hospital uncovered a means to study the complexity of this disease beyond the identification of individual genes. This new approach offers a path toward treating HCM using individualized medicine. ...

Nuclear physicists on the hunt for squeezed protons

Nuclear physicists on the hunt for squeezed protons
2021-02-25
While protons populate the nucleus of every atom in the universe, sometimes they can be squeezed into a smaller size and slip out of the nucleus for a romp on their own. Observing these squeezed protons may offer unique insights into the particles that build our universe. Now, researchers hunting for these squeezed protons at the U.S. Department of Energy's Thomas Jefferson National Accelerator Facility have come up empty handed, suggesting there's more to the phenomenon than first thought. The result was recently published in Physical Review Letters. "We were looking to squeeze the proton such that its quarks are in a small-size configuration. And that's a pretty tough ...

OU study highlights need for improving methane emission database

2021-02-25
A University of Oklahoma-led study published in 2020 revealed that both area and plant growth of paddy rice is significantly related to the spatial-temporal dynamics of atmospheric methane concentration in monsoon Asia, where 87% of the world's paddy rice fields are situated. Now, the same international research team has released a follow-up discussion paper in the journal Nature Communications. In this paper, the team identifies the limits and insufficiency of the major greenhouse emission database (EDGAR) in estimating paddy rice methane emissions. "Methane emission from paddy ...

UTEP survey reveals hidden health and wellness benefits of COVID-19 pandemic

UTEP survey reveals hidden health and wellness benefits of COVID-19 pandemic
2021-02-25
EL PASO, Texas - A study by physiology researchers at The University of Texas at El Paso found that El Paso's stay-at-home ordinance due to the COVID-19 pandemic had positive effects on the health and well-being of the region's residents. Despite a shutdown of gyms and movement restrictions on non-essential activities, residents increased their fitness activity and closely monitored their food and nutrition intake, said Cory M. Smith, Ph.D., assistant professor of kinesiology in UTEP's College of Health Sciences and the study's principal investigator. More than 1,300 El Paso and ...

Landmark study details sequencing of 64 full human genomes to better capture genetic diversity

Landmark study details sequencing of 64 full human genomes to better capture genetic diversity
2021-02-25
Researchers at the University of Maryland School of Medicine (UMSOM) co-authored a study, published today in the journal Science, that details the sequencing of 64 full human genomes. This reference data includes individuals from around the world and better captures the genetic diversity of the human species. Among other applications, the work will enable population-specific studies on genetic predispositions to human diseases as well as the discovery of more complex forms of genetic variation. Twenty years ago this month, the International Human Genome Sequencing Consortium announced the first draft of the human genome reference sequence. The Human Genome Project, as it was called, required 11 years of work and involved more than 1000 ...

What might sheep and driverless cars have in common? Following the herd

2021-02-25
Psychologists have long found that people behave differently than when they learn of peers' actions. A new study by computer scientists found that when individuals in an experiment about autonomous vehicles were informed that their peers were more likely to sacrifice their own safety to program their vehicle to hit a wall rather than hit pedestrians who were at risk, the percentage of individuals willing to sacrifice their own safety increased by approximately two-thirds. As computer scientists train machines to act as people's agents in all sorts of situations, the study's authors indicate that the social component of decision-making is often overlooked. This could be of great consequence, note the paper's authors who show that the trolly problem -long shown to be ...

Study uncovers flaws in process for maintaining state voter rolls

2021-02-25
States regularly use administrative records, such as motor-vehicle data, in determining whether people have moved to prune their voter rolls. A Yale-led study of this process in Wisconsin shows that a significant percentage of registered voters are incorrectly identified as having changed addresses, potentially endangering their right to vote. The study, published in the journal Science Advances, found that at least 4% of people listed as suspected "movers" cast ballots in 2018 elections using addresses that were wrongly flagged as out of date. Minority voters were twice as likely as white voters to cast their ...

LAST 30 PRESS RELEASES:

E-cigarettes with a cigarette-like level of nicotine are effective in reducing smoking

Deep Learning model developed at UHN to maximize lifespan after liver transplant 

Convenience over reputation: Study looks at how older adults pick a doctor

Ocean bacteria release carbon into the atmosphere

Spotting cows from space

Scientists watch 2D puddles of electrons emerge in a 3D superconducting material

Research suggests SEC's increasing focus on terrorism may limit financial oversight

Plastic planet: Tracking pervasive microplastics across the globe

Gut epithelium muscles up against infection

Scientists discover three liquid phases in aerosol particles

New mechanism identified behind blindness in older adults

Common approach to diversity in higher education reflects preferences of white Americans

Study reveals cancer immunotherapy patients at most risk of life-threatening side effects

Study reveals crucial details on skin-related side effects of cancer immune therapies

Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates

Differences in B cell responses to coronaviruses and other pathogens in children and adults

Bottom-up is the way forward for nitrogen reduction at institutions

Road salts and other human sources are threatening world's freshwater supplies

Researchers engineer probiotic yeast to produce beta-carotene

Spanking may affect the brain development of a child

UConn researchers find bubbles speed up energy transfer

Antidepressant use in pregnancy tied to affective disorders in offspring; no causal link

Binge-eating is not caused by stress-induced impulsivity

Stress does not lead to loss of self-control in eating disorders

USC Stem Cell study reveals neural stem cells age rapidly

Following atoms in real time could lead to better materials design

People want to improve mental health by exercising, but stress and anxiety get in the way

More than the sum of mutations

Living foams

Research brief: How pharmacists contribute meaningfully in primary health care

[Press-News.org] Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients